En esta página
IVVD Invivyd, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 13, 2026
$0,82
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,53mínimo 52 semanas
$3,07máximo 52 semanas
Capitalización Bursátil (MRQ)
$242M
P/E (TTM)
-2.7
BPA (TTM)
$-0.31
Ingresos (TTM)
$58M
tus insignias
Rango 52S
$1–$3
Calificación del Analista
BUY
Precio Objetivo
$10
P/E
-2.7
ROE
-95.9%
Margen de Beneficio Neto
-183.9%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
IVVD Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.82
Capitalización Bursátil (MRQ)
$242M
P/E (TTM)
-2.7
BPA (TTM)
$-0.31
Ingresos (TTM)
$58M
ROE (TTM)
-95.9%
Rango 52S
$1–$3
IVVD Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$53M2023-12-31 → 2025-12-31
BPA$-0.302021-12-31 → 2025-12-31
Flujo de caja libre$-58M2022-12-31 → 2025-12-31
Margen neto-183.9%2024-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | IVVD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -2.7promedio 5A ≈-2.6 | ≈-2.6 | · | · | |
| P/S (TTM) | 4.2 | · | 44.0 | Infravalorado | |
| P/C (MRQ) | 1.3promedio 5A ≈1.6 | ≈1.6 | 2.1 | Infravalorado | |
| Precio / FCF (TTM) | -2.2promedio 5A ≈-3.9 | ≈-3.9 | · | · | |
| Precio / Flujo de Caja (TTM) | -2.2promedio 5A ≈-3.9 | ≈-3.9 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.0promedio 5A ≈1.6 | ≈1.6 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | IVVD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -192.8% | · | -320.8% | En línea | |
| EBITDA Margin (Margen EBITDA) | -104.0% | · | -320.8% | En línea | |
| Margen de Beneficio Neto (TTM) | -183.9% | · | -692.5% | De primer nivel | |
| ROA (TTM) | -69.7%promedio 5A ≈-58.4% | ≈-58.4% | -29.4% | De primer nivel | |
| ROE (TTM) | -95.9%promedio 5A ≈-105.5% | ≈-105.5% | -47.7% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | IVVD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 5.9promedio 5A ≈7.1 | ≈7.1 | 7.5 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 7.0promedio 5A ≈4.0 | ≈4.0 | 5.5 | En línea |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | IVVD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 110.5% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | IVVD | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.3 | · | 0.1 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 4.3 | · | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$437.9K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-130.4%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 13, 2026 | $-0.14 | $-0.11 | -28.7% |
| 31 de marzo de 2026 | May 14, 2026 | $-0.13 | $-0.07 | -73.8% |
| 31 de diciembre de 2025 | $-0.04 | $-0.09 | 55.2% | |
| 30 de septiembre de 2025 | $-0.06 | $-0.08 | 26.5% | |
| 30 de junio de 2025 | $-0.12 | $-0.02 | -404.2% | |
| 31 de marzo de 2025 | $-0.14 | $-0.03 | -357.5% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $53M | $25M | $0 | |
| R&D Expense | $38M | $137M | $159M | |
| SG&A Expense | $67M | $63M | $49M | |
| Operating Expenses | $109M | $202M | $213M | |
| Operating Income | $-56M | $-177M | $-213M | |
| Other Non-op | $3M | $7M | $14M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-52M | $-170M | $-199M | |
| EPS (Basic) | $-0.30 | $-1.43 | $-1.81 | |
| EPS (Diluted) | $-0.30 | $-1.43 | $-1.81 | |
| Shares (Basic) | 172,212,902 | 118,555,073 | 109,526,053 | |
| Shares (Diluted) | 172,212,902 | 118,555,073 | 109,526,053 | |
| EBITDA | $-56M | $-177M | $-213M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $227M | $69M | $201M | |
| Receivables | $14M | $11M | $0 | |
| Inventory | · | $26M | $0 | |
| Prepaid Expense | $7M | $20M | $24M | |
| Other Current Assets | · | $4M | · | |
| Current Assets | $247M | $101M | $225M | |
| PP&E (Net) | $1M | $2M | $2M | |
| Other Non-current Assets | $110.0K | $34.0K | $175.0K | |
| Total Assets | $277M | $130M | $229M | |
| Accounts Payable | $14M | $10M | $8M | |
| Accrued Liabilities | $19M | $50M | $41M | |
| Current Liabilities | $34M | $62M | $50M | |
| Capital Leases | $1M | $0 | $722.0K | |
| Other Non-current Liabilities | · | $0 | $700.0K | |
| Total Liabilities | $35M | $62M | $52M | |
| Common Stock | $28.0K | $12.0K | $11.0K | |
| Retained Earnings | $-954M | $-902M | $-732M | |
| AOCI | $-41.0K | $-5.0K | $-13.0K | |
| Stockholders' Equity | $242M | $68M | $177M | |
| Liabilities + Equity | $277M | $130M | $229M | |
| Shares Outstanding | 281,987,033 | 119,835,162 | 110,160,684 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $12M | $20M | $19M | |
| Operating Cash Flow | $-58M | $-170M | $-173M | |
| CapEx | $155.0K | $140.0K | $615.0K | |
| Investing Cash Flow | $-155.0K | $-140.0K | $281M | |
| Stock Issued | $254.0K | $223.0K | $240.0K | |
| Stock Repurchased | · | $0 | $1.0K | |
| Net Stock Activity | $254.0K | $223.0K | $239.0K | |
| Financing Cash Flow | $216M | $39M | $1M | |
| Net Change in Cash | $157M | $-131M | $109M | |
| Free Cash Flow | $-58M | $-171M | $-174M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -104.0% | -696.8% | · | |
| Net Margin | -98.2% | -669.4% | · | |
| EBITDA Margin | -104.0% | -696.8% | · | |
| ROA | -25.8% | -94.8% | -64.9% | |
| ROE | -36.9% | -225.5% | -93.7% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.2 | 1.6 | 4.5 | |
| Quick Ratio | 7.0 | 1.3 | 4.0 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | · | |
| Receivables Turnover | 4.3 | 4.7 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $0.86 | $0.56 | $1.61 | |
| Revenue / Share | $0.31 | $0.21 | · | |
| Cash Flow / Share | $-0.34 | $-1.44 | $-1.58 | |
| Cash / Share | $0.80 | $0.58 | $1.82 | |
| EPS (TTM) | $-0.30 | $-1.43 | $-1.81 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 110.5% | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $53M | $25M | $0 | |
| Net Income TTM | $-52M | $-170M | $-199M | |
| Market Cap | $697M | $53M | $434M | |
| P/E | -8.2 | -0.3 | -2.2 | |
| P/S | 13.0 | 2.1 | · | |
| P/B | 2.9 | 0.8 | 2.4 | |
| P / Tangible Book | 2.9 | 0.8 | 2.4 | |
| P / Cash Flow | -12.0 | -0.3 | -2.5 | |
| P / FCF | -11.9 | -0.3 | -2.5 | |
| Earnings Yield | -12.2% | -322.8% | -45.9% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $14M | $17M | $13M | $12M | $11M | $14M | $9M | $2M | $0 | $0 | $0 | $0 | |
| R&D Expense | $29M | $31M | $10M | $8M | $10M | $11M | $18M | $58M | $30M | $31M | $62M | $26M | $44M | |
| SG&A Expense | $29M | $25M | $19M | $15M | $17M | $17M | $14M | $13M | $21M | $15M | $15M | $13M | $10M | |
| Operating Expenses | $60M | $57M | $30M | $24M | $27M | $28M | $33M | $72M | $52M | $46M | $77M | $43M | $54M | |
| Operating Income | $-46M | $-43M | $-13M | $-11M | $-15M | $-17M | $-19M | $-62M | $-49M | $-46M | $-77M | $-43M | $-54M | |
| Other Non-op | $1M | $2M | $1M | $553.0K | $400.0K | $633.0K | $786.0K | $2M | $2M | $3M | $3M | $4M | $4M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-44M | $-41M | $-11M | $-10M | $-15M | $-16M | $-18M | $-61M | $-47M | $-43M | $-74M | $-39M | $-50M | |
| EPS (Basic) | $-0.14 | $-0.13 | $0.02 | $-0.06 | $-0.12 | $-0.14 | $-0.14 | $-0.51 | $-0.40 | $-0.38 | $-0.67 | $-0.36 | $-0.46 | |
| EPS (Diluted) | $-0.14 | $-0.13 | $0.02 | $-0.06 | $-0.12 | $-0.14 | $-0.14 | $-0.51 | $-0.40 | $-0.38 | $-0.67 | $-0.36 | $-0.46 | |
| Shares (Basic) | 320,435,078 | 309,670,101 | · | 170,169,865 | 120,016,132 | 119,883,479 | · | 119,495,284 | 119,362,670 | 115,618,209 | · | 109,754,812 | 109,450,071 | |
| Shares (Diluted) | 320,435,078 | 309,670,101 | · | 170,169,865 | 120,016,132 | 119,883,479 | · | 119,495,284 | 119,362,670 | 115,618,209 | · | 109,754,812 | 109,450,071 | |
| EBITDA | $-46M | $-43M | · | $-11M | $-15M | $-17M | · | $-62M | $-49M | $-46M | · | $-43M | $-54M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $184M | $227M | $85M | $35M | $48M | $69M | $107M | $148M | $189M | $201M | $182M | $122M | |
| Receivables | $11M | $12M | $14M | $10M | $9M | $9M | $11M | $8M | $3M | · | $0 | · | · | |
| Inventory | · | · | · | $25M | $25M | $25M | · | $27M | $5M | $109.0K | $0 | · | · | |
| Prepaid Expense | $11M | $9M | $7M | $15M | $16M | $19M | $20M | $9M | $17M | $20M | $24M | $5M | $12M | |
| Other Current Assets | · | · | · | · | $2M | · | · | · | · | · | · | · | · | |
| Current Assets | $182M | $205M | $247M | $110M | $59M | $76M | $101M | $151M | $173M | $210M | $225M | $270M | $310M | |
| PP&E (Net) | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $1M | $1M | $110.0K | $6.0K | $15.0K | $24.0K | $34.0K | $7M | $2M | $2M | $175.0K | $187.0K | $291.0K | |
| Total Assets | $219M | $242M | $277M | $139M | $89M | $104M | $130M | $162M | $177M | $215M | $229M | $275M | $315M | |
| Accounts Payable | $9M | $2M | $14M | $18M | $18M | $9M | $10M | $18M | $7M | $1M | $8M | $9M | $4M | |
| Accrued Liabilities | $20M | $28M | $19M | $25M | $25M | $40M | $50M | $59M | $27M | $34M | $41M | $16M | $27M | |
| Current Liabilities | $31M | $32M | $34M | $44M | $44M | $50M | $62M | $79M | $37M | $36M | $50M | $27M | $33M | |
| Capital Leases | $7M | $7M | $1M | $2M | $2M | $0 | $0 | $219.0K | $0 | $625.0K | $722.0K | $927.0K | $1M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | $700.0K | $700.0K | · | |
| Total Liabilities | $38M | $39M | $35M | $46M | $46M | $50M | $62M | $79M | $37M | $37M | $52M | $28M | $34M | |
| Common Stock | $29.0K | $28.0K | $28.0K | $22.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $11.0K | $11.0K | $11.0K | |
| Retained Earnings | $-1.04B | $-996M | $-954M | $-943M | $-933M | $-918M | $-902M | $-884M | $-823M | $-776M | $-732M | $-658M | $-619M | |
| AOCI | $-35.0K | $-37.0K | $-41.0K | $-41.0K | $-39.0K | $-13.0K | $-5.0K | $-18.0K | $-12.0K | $-12.0K | $-13.0K | $-2.0K | $-22.0K | |
| Stockholders' Equity | $181M | $203M | $242M | $93M | $43M | $54M | $68M | $83M | $141M | $178M | $177M | $246M | $282M | |
| Liabilities + Equity | $219M | $242M | $277M | $139M | $89M | $104M | $130M | $162M | $177M | $215M | $229M | $275M | $315M | |
| Shares Outstanding | 294,755,090 | 282,803,863 | 281,987,033 | 214,409,450 | 120,142,811 | 119,961,445 | 119,835,162 | 119,604,035 | 119,442,635 | 119,221,230 | 110,160,684 | 109,846,329 | 109,570,333 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $8M | $5M | $4M | $4M | $5M | |
| Operating Cash Flow | $-43M | $-42M | $-15M | $-8M | $-13M | $-21M | $-38M | $-41M | $-42M | $-50M | $-59M | $-35M | $-37M | |
| CapEx | $510.0K | $726.0K | $0 | $0 | $11.0K | $144.0K | $-5.0K | $5.0K | $0 | $140.0K | $0 | $0 | $-9.0K | |
| Investing Cash Flow | $-510.0K | $-726.0K | $0 | $0 | $-11.0K | $-144.0K | $5.0K | $-5.0K | $0 | $-140.0K | $78M | $95M | $33M | |
| Stock Issued | $120.0K | $135.0K | $76.0K | $56.0K | $78.0K | $44.0K | $32.0K | $27.0K | $75.0K | $89.0K | $44.0K | $57.0K | $56.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | $1.0K | |
| Net Stock Activity | · | $135.0K | · | · | · | $44.0K | · | · | · | $89.0K | · | · | · | |
| Financing Cash Flow | $19M | $-98.0K | $157M | $58M | $131.0K | $10.0K | $77.0K | $61.0K | $92.0K | $39M | $141.0K | $92.0K | $270.0K | |
| Net Change in Cash | $-24M | $-43M | $142M | $50M | $-13M | $-21M | $-38M | $-41M | $-42M | $-11M | $19M | $60M | $-5M | |
| Free Cash Flow | · | $-42M | · | · | · | $-21M | · | · | · | $-50M | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -320.8% | -313.9% | · | -84.0% | -127.8% | -149.7% | · | -670.0% | -2175.2% | · | · | · | · | |
| Net Margin | -310.8% | -301.2% | · | -79.8% | -124.4% | -144.1% | · | -653.1% | -2086.9% | · | · | · | · | |
| EBITDA Margin | -320.8% | -313.9% | · | -84.0% | -127.8% | -149.7% | · | -670.0% | -2175.2% | · | · | · | · | |
| ROA | -28.8% | -24.0% | · | -7.0% | -11.0% | -10.2% | · | -27.8% | -19.2% | -15.4% | · | -11.3% | -12.6% | |
| ROE | -39.7% | -32.2% | · | -11.9% | -16.0% | -14.0% | · | -36.9% | -22.4% | -17.2% | · | -12.6% | -14.4% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 6.5 | · | 2.5 | 1.3 | 1.5 | · | 1.9 | 4.7 | 5.8 | · | 10.1 | 9.5 | |
| Quick Ratio | 5.5 | 6.2 | · | 2.1 | 1.0 | 1.1 | · | 1.5 | 4.1 | 5.2 | · | 6.8 | 3.8 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 2.0 | 2.6 | · | 2.3 | 1.6 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.61 | $0.72 | · | $0.43 | $0.36 | $0.45 | · | $0.70 | $1.18 | $1.50 | · | $2.24 | $2.57 | |
| Revenue / Share | $0.04 | $0.04 | · | $0.08 | $0.10 | $0.09 | · | $0.08 | $0.02 | · | · | · | · | |
| Cash Flow / Share | · | $-0.13 | · | · | · | $-0.18 | · | · | · | $-0.43 | · | · | · | |
| Cash / Share | $0.54 | $0.65 | · | $0.40 | $0.29 | $0.40 | · | $0.89 | $1.24 | $1.59 | · | $1.66 | $1.11 | |
| EPS (TTM) | $-0.31 | $-0.29 | · | $-0.46 | $-0.91 | $-1.19 | · | $-1.96 | $-1.81 | $-1.87 | · | $-1.55 | $-1.61 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $58M | $56M | · | $50M | $46M | $37M | · | $12M | $2M | $0 | · | · | · | |
| Net Income TTM | $-107M | $-78M | · | $-60M | $-110M | $-143M | · | $-225M | $-204M | $-207M | · | $-170M | $-175M | |
| Market Cap | $257M | $368M | · | $236M | $86M | $73M | · | $122M | $131M | $529M | · | $187M | $115M | |
| P/E | -2.8 | -4.5 | · | -2.4 | -0.8 | -0.5 | · | -0.5 | -0.6 | -2.4 | · | -1.1 | -0.7 | |
| P/S | 4.4 | 6.6 | · | 4.7 | 1.9 | 2.0 | · | 10.5 | 58.0 | · | · | · | · | |
| P/B | 1.4 | 1.8 | · | 2.5 | 2.0 | 1.3 | · | 1.5 | 0.9 | 3.0 | · | 0.8 | 0.4 | |
| P / Tangible Book | 1.4 | 1.8 | · | 2.5 | 2.0 | 1.3 | · | 1.5 | 0.9 | 3.0 | · | 0.8 | 0.4 | |
| P / Cash Flow | · | -8.8 | · | · | · | -3.4 | · | · | · | -10.5 | · | · | · | |
| Earnings Yield | -35.5% | -22.3% | · | -41.8% | -127.3% | -196.7% | · | -192.2% | -164.5% | -42.1% | · | -91.2% | -153.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $53M | $25M | $0 | · | · |
| Margen Operativo % | -104.0% | -696.8% | · | · | · |
| Beneficio neto | $-52M | $-170M | $-199M | $-241M | $-227M |
| EPS Diluido | $-0.30 | $-1.43 | $-1.81 | $-2.23 | $-5.32 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 7.2 | 1.6 | 4.5 | 15.1 | · |
| Ratio Rápido | 7.0 | 1.3 | 4.0 | 3.7 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-58M | $-171M | $-174M | $-222M | · |
Propietarios institucionales (13F) 139 declarantes · $257.2M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
139
Valor en tenencia
$257.2M
Nuevas posiciones
34
Posiciones cerradas
43
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 34 (-9 vs trimestre anterior) | 43 (+29 vs trimestre anterior) | 41 (+3 vs trimestre anterior) | 28 (-2 vs trimestre anterior) | -26.3M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $42 857 157 | 33 094 330 | 16,66% | Acciones |
| VANGUARD GROUP INC | $26 438 823 | 10 703 977 | 10,28% | Acciones |
| BVF INC/IL | $24 571 146 | 28 165 000 | 9,55% | Acciones |
| MAVERICK CAPITAL LTD | $16 550 225 | 18 970 913 | 6,44% | Acciones |
| PERCEPTIVE ADVISORS LLC | $16 131 231 | 18 490 636 | 6,27% | Acciones |
| BlackRock, Inc. | $14 076 073 | 16 134 885 | 5,47% | Acciones |
| Mithril II GP LP | $12 365 738 | 11 241 580 | 4,81% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $9 152 954 | 10 496 507 | 3,56% | Acciones |
| M28 Capital Management LP | $8 068 173 | 9 248 250 | 3,14% | Acciones |
| Saturn V Capital Management LP | $7 321 432 | 8 392 288 | 2,85% | Acciones |
| Soleus Capital Management, L.P. | $6 725 093 | 7 708 727 | 2,61% | Acciones |
| Point72 Asset Management, L.P. | $6 579 694 | 7 542 061 | 2,56% | Acciones |
| MORGAN STANLEY | $4 999 678 | 5 730 948 | 1,94% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $4 728 560 | 5 418 774 | 1,84% | Acciones |
| Siren, L.L.C. | $4 362 000 | 5 000 000 | 1,70% | Acciones |
| Driehaus Capital Management LLC | $4 193 228 | 4 806 543 | 1,63% | Acciones |
| ADAR1 Capital Management, LLC | $3 321 599 | 3 807 427 | 1,29% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3 194 275 | 3 661 480 | 1,24% | Acciones |
| CITADEL ADVISORS LLC | $3 124 013 | 3 580 941 | 1,21% | Acciones |
| STATE STREET CORP | $3 016 260 | 3 457 428 | 1,17% | Acciones |
| Qube Research & Technologies Ltd | $2 896 576 | 3 320 238 | 1,13% | Acciones |
| Ikarian Capital, LLC | $2 317 592 | 2 656 570 | 0,90% | Acciones |
| Redmile Group, LLC | $2 266 285 | 2 597 759 | 0,88% | Acciones |
| TWO SIGMA ADVISERS, LP | $2 264 002 | 916 600 | 0,88% | Acciones |
| 683 Capital Management, LLC | $2 165 770 | 2 482 543 | 0,84% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $2 035 723 | 2 333 474 | 0,79% | Acciones |
| Eversept Partners, LP | $1 951 572 | 2 237 015 | 0,76% | Acciones |
| Ensign Peak Advisors, Inc | $1 501 641 | 1 721 276 | 0,58% | Acciones |
| NORTHERN TRUST CORP | $1 404 872 | 1 610 353 | 0,55% | Acciones |
| Boxer Capital Management, LLC | $1 308 600 | 1 500 000 | 0,51% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 272 258 | 1 459 012 | 0,49% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 236 262 | 1 417 732 | 0,48% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $1 051 765 | 1 205 599 | 0,41% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $868 329 | 995 334 | 0,34% | Acciones |
| GOLDMAN SACHS GROUP INC | $853 689 | 978 552 | 0,33% | Acciones |
| DEUTSCHE BANK AG\ | $687 952 | 790 749 | 0,27% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $675 792 | 774 635 | 0,26% | Acciones |
| UBS Group AG | $481 570 | 552 260 | 0,19% | Acciones |
| Bank of New York Mellon Corp | $451 833 | 517 920 | 0,18% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $409 781 | 469 717 | 0,16% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $397 412 | 455 539 | 0,15% | Acciones |
| Invesco Ltd. | $396 532 | 454 530 | 0,15% | Acciones |
| CANTOR FITZGERALD, L. P. | $392 680 | 450 115 | 0,15% | Acciones |
| EMERALD MUTUAL FUND ADVISERS TRUST | $374 126 | 428 847 | 0,15% | Acciones |
| Virtus Investment Advisers, LLC | $370 712 | 424 933 | 0,14% | Acciones |
| BANK OF AMERICA CORP /DE/ | $311 234 | 356 920 | 0,12% | Acciones |
| Birchview Capital, LP | $298 601 | 342 275 | 0,12% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $281 097 | 323 100 | 0,11% | Opción de venta |
| Nuveen, LLC | $244 563 | 280 333 | 0,10% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $241 599 | 277 700 | 0,09% | Opción de compra |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Adimab, LLC ×6 presentaciones | 29 de diciembre de 2025 | 7,30% | Enmienda | · | SEC |
| Mithril II LP, Mithril II GP LP, Mithril II UGP LLC, Ajay Royan, Peter Thiel ×6 presentaciones | 12 de noviembre de 2025 | 4,80% | Enmienda | · | SEC |
| Polaris Venture Partners V, L.P., Polaris Venture Partners Entrepreneurs' Fund V, L.P., Polaris Venture Partners Founders' Fund V, L.P., Polaris Venture Partners Special Founders' Fund V, L.P., Polaris Venture Management Co. V, L.L.C., Polaris Partners IX, L.P., Polaris Partners GP IX, L.L.C., Polaris Healthcare Technology Opportunities Fund, L.P., Polaris Healthcare Technology Opportunities Fund GP, L.L.C., Terrance McGuire, Jonathan Flint ×6 presentaciones | 7 de noviembre de 2025 | 3,00% | Enmienda | · | SEC |
| M28 Capital Management LP, Marc Elia ×5 presentaciones | 26 de agosto de 2025 | 4,60% | Enmienda | · | SEC |
| Population Health Equity Partners III, L.P., Population Health Equity Partners III GP, LLC, Population Health Equity Partners VII, L.P., Population Health Equity Partners VII GP, LLC, Clive Meanwell, Christopher Cox ×3 presentaciones | 24 de junio de 2022 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 33 insiders · 15 directivos · 19 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Marc Elia | Chief Executive Officer | 30 de agosto de 2026 A | · | 0 | 0 | $0 |
| David Hering | Chief Executive Officer | 18 de diciembre de 2023 A | 8 000 | 0 | 0 | $0 |
| Tillman U. Gerngross | Chief Executive Officer | 30 de enero de 2022 A | 27 845 995 | 0 | 0 | $0 |
| William E. Duke | Chief Financial Officer | 15 de agosto de 2026 M | 168 937 | 0 | 4 | $-94 977 |
| Jane Henderson | Chief Financial Officer | 30 de enero de 2022 A | · | 0 | 0 | $0 |
| Jeremy Gowler | COO & CCO | 18 de diciembre de 2023 A | · | 0 | 0 | $0 |
| Timothy Edward Lee | Chief Commercial Officer | 15 de agosto de 2026 M | 178 937 | 0 | 4 | $-94 977 |
| Julie Green | Chief Human Resources Officer | 15 de agosto de 2026 M | 168 937 | 0 | 4 | $-94 977 |
| Robert D. Allen III | Chief Scientific Officer | 15 de agosto de 2026 M | 178 765 | 0 | 4 | $-87 855 |
| Jill Andersen | Chief Legal Officer, Secretary | 15 de agosto de 2026 M | 283 774 | 0 | 4 | $-158 288 |
| Stacy Price | Chief Tech. and Manuf. Officer | 18 de diciembre de 2023 A | · | 0 | 0 | $0 |
| Peter Schmidt | Chief Medical Officer | 18 de diciembre de 2023 A | · | 0 | 0 | $0 |
| Rebecca Dabora | Chief Tech and Manuf Officer | 14 de diciembre de 2022 A | · | 0 | 0 | $0 |
| Lynn Connolly | Chief Medical Officer | 30 de enero de 2022 A | · | 0 | 0 | $0 |
| Elham Hershberger | Chief Development Officer | 30 de enero de 2022 A | · | 0 | 0 | $0 |
| Ian Sheffield | Consejero | 31 de agosto de 2026 A | · | 0 | 0 | $0 |
| Tamsin Berry | Consejero | 19 de mayo de 2026 A | · | 0 | 0 | $0 |
| Ajay Royan | Consejero | 19 de mayo de 2026 A | 11 241 580 | 0 | 0 | $0 |
| Paul Bolno | Consejero | 19 de mayo de 2026 A | · | 0 | 0 | $0 |
| Kevin F Mclaughlin | Consejero | 19 de mayo de 2026 A | 50 000 | 1 | 0 | $125 000 |
| Terrance McGuire | Consejero | 19 de mayo de 2026 A | 3 066 757 | 0 | 0 | $0 |
| Christine Lindenboom | Consejero | 20 de mayo de 2025 A | · | 0 | 0 | $0 |
| Srishti Gupta | Consejero | 21 de mayo de 2024 A | · | 0 | 0 | $0 |
| Sara Cotter | Consejero | 21 de mayo de 2024 A | · | 0 | 0 | $0 |
| Tomas J. Heyman | Consejero | 23 de mayo de 2023 A | · | 0 | 0 | $0 |
| Clive Meanwell | Consejero | 23 de mayo de 2023 A | · | 0 | 0 | $0 |
| Michael S Wyzga | Consejero | 23 de mayo de 2023 A | · | 0 | 0 | $0 |
| Redonda Miller | Consejero | 22 de junio de 2022 A | · | 0 | 0 | $0 |
| Howard Mayer | Consejero | 22 de junio de 2022 A | · | 0 | 0 | $0 |
| Ellen R Marram | Consejero | 19 de noviembre de 2021 A | · | 0 | 0 | $0 |
| Rene Russo | Consejero | 5 de agosto de 2021 A | · | 0 | 0 | $0 |
| Adimab, LLC | Propietario del 10% | 19 de enero de 2024 S | 21 687 906 | 0 | 0 | $0 |
| Michael Mina | · | 31 de julio de 2026 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 13 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,47% | 403 655 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,04% | 719 785 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 20 848 SH | 2 de octubre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 405 677 SH | 2 de octubre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1 216 850 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 182 982 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 5 586 643 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 100 540 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 589 919 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 2 434 423 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 7 785 522 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 17 900 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 2 013 518 SH | 11 de septiembre de 2026 | Diario |
IVVD Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 9 analistas
COMPRA
Objetivo mediano
$10.00
+1116,4%
3 33,3%
Compra fuerte
5 55,6%
Compra
1 11,1%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
3 analistas · 2026-09-27Objetivo medio $10.00 +1116,4%
Mín$10.00
Media$10.00
Máx$10.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| GLSI | $300M | -14.7 | · | · | -2159.7% | · |
| QTTB | $43M | 1.4 | · | 55.5% | 200.3% | · |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 13, 2026